Royalty Pharma (RPRX) FCF Payout Ratio (2019 - 2026)

Royalty Pharma has reported FCF Payout Ratio for 8 years, with the latest figure at 0.15 in Q1 2026.

• Quarterly FCF Payout Ratio rose 65.8% year-over-year to 0.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.33 (down 36.88% YoY) and the FY2025 annual result came in at 0.21, down 55.52% from the prior year.
• FCF Payout Ratio slipped to 0.15 in Q1 2026 per RPRX's latest filing, from 0.44 in the prior quarter.
• Over five years, FCF Payout Ratio peaked at 0.44 in Q4 2025 and troughed at 0.44 in Q2 2024.
• A 5-year average of 0.05 and a median of 0.08 in 2023 frame the typical range for FCF Payout Ratio.
• The sharpest annual moves came in 2023 and 2024: FCF Payout Ratio jumped 611.91% in 2023, then slumped 881.2% in 2024.
• Over 5 years, FCF Payout Ratio stood at 0.1 in 2022, then tumbled by 202.85% to 0.11 in 2023, then soared by 219.81% to 0.13 in 2024, then surged by 241.26% to 0.44 in 2025, then sank by 65.6% to 0.15 in 2026.
• According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.15, 0.44, and 0.13 for Q1 2026, Q4 2025, and Q3 2025 respectively.